Board meeting scheduled March 31, 2026 to consider increase in authorised share capital subject to shareholder approval.
Company proposes fundraising via equity shares, convertible instruments, preferential allotment, rights issue, QIP, ADR/GDR, or FCCB.
Board to also consider EGM convening, CSR project status update, and revision in Gautam Medical College & Hospital project cost.
Trading window closed from March 23, 2026 until 48 hours after board meeting closure per SEBI Insider Trading Regulations.